Publisher's Synopsis
This volume addresses the question of how knowledge of epigenetic phenomena like DNA methylation and acetylation can be applied to early cancer detection and risk assessment. The objectives of the papers include defining the terminology used in epigenetics, identifying and prioritizing areas of research in epigenetics, reviewing cutting-edge technology available for quantitation of methylation and high-throughput assays, and discussing clinical correlates to epigenetic changes.
